Device and method for releasing catheters from cardiac structures

Abstract
Devices, systems, and methods for releasing a catheter from an implant may include a catheter comprising first and second elongate elements, first and second elongate element lumens, a tissue anchor lumen, apertures corresponding to each of the lumens, and retaining portions between adjacent apertures. The first elongate element may extend out of its lumen through the first elongate element aperture, across the retaining portion transversely with respect to a longitudinal axis, and towards the second elongate element aperture. The first elongate element may then extend into the second elongate element aperture, loop over the second elongate element, and extend back across the retaining portion and into the first elongate element lumen. In some instances, the second elongate element is retracted to uncouple the first and second elongate elements from each other and to open a channel for the release of tethered tissue anchors.
Description
FIELD

The present invention is directed toward devices, systems, and methods for performing a heart procedure.


BACKGROUND

Blood returning to the heart from peripheral circulation and the lungs generally flows into the atrial chambers of the heart and then to the ventricular chambers, which pump the blood back out of the heart. During ventricular contraction, the atrio-ventricular valves between the atria and ventricles (i.e. the tricuspid and mitral valves), close to prevent backflow or regurgitation of blood from the ventricles back to the atria. The closure of these valves, along with the aortic and pulmonary valves, maintains the unidirectional flow of blood through the cardiovascular system. Disease of the valves can result in valve dysfunction, where some fraction of the ventricular blood regurgitates back into the atrial chambers.


Treatment of heart valve stenosis or regurgitation, such as mitral or tricuspid regurgitation, may involve an open-heart surgical procedure to replace or repair the valve. Methods and devices have been developed to accomplish ventriculoplasty on the left ventricle of the human heart for patients suffering from functional mitral valve regurgitation and/or congestive heart failure. A device such as a delivery catheter may be advanced into the heart to place a set of anchors within the left ventricular myocardium in a subannular region between the mitral annulus and the papillary muscles. The anchors are coupled together by a tether. Once the anchors and tether are released, the tether is cinched in order to reduce the mitral annulus, creating mitral valve competence and relieving left ventricle wall stress. Additional devices and methods for releasing anchor structures from a catheter may be desirable.


BRIEF SUMMARY

Described here are devices, systems, and methods for removing a catheter from a body organ. In general, the systems described here for delivering an implant comprise a catheter comprising a longitudinal axis, a first elongate element lumen, a second elongate element lumen, a tissue anchor lumen, and a plurality of apertures along the longitudinal axis. The plurality of apertures may comprise first elongate element apertures, second elongate element apertures, and tissue anchor apertures. The catheter may further comprise a plurality of retaining portions each between adjacent tissue anchor apertures and between adjacent first and second elongate element apertures. A first elongate element may be disposed within the first elongate element lumen. A second elongate element may be disposed within the second elongate element lumen. For each pair of adjacent first and second elongate element apertures, the first elongate element may extend out of the first elongate element lumen through the first elongate element aperture across the retaining portion transversely with respect to the longitudinal axis and towards the second elongate element aperture. The first elongate element may extend into the second elongate element aperture, loop over the second elongate element, and extend back across the retaining portion and into the first elongate element lumen.


In some variations, the first elongate element may be releasably coupled to the second elongate element. In other variations, the first elongate element extending between the first and second elongate element apertures may cross over itself. In yet other variations, the first elongate element may be fixed to a distal end of the catheter.


In some variations, a first elongate element control may be configured to retract the first elongate element from the first elongate element lumen and a second elongate element control may be configured to retract the second elongate element from the second elongate element lumen. In some of these variations, retracting the first elongate element from the first elongate element lumen may tension the first elongate element.


In some variations, the plurality of retaining portions may each comprise a channel along the longitudinal axis. In some of these variations, the plurality of retaining portions may be each adapted to open the channel.


In yet further variations, at least one radiopaque structure may be located between the plurality of apertures.


In some variations, an anchor delivery catheter may be advanceable within the catheter and a plurality of tissue anchors within the anchor delivery catheter. In some of these variations, the tissue anchor apertures may be configured for passage of the plurality of tissue anchors. In another of these variations, the anchor delivery catheter may be advanceable within the tissue anchor lumen.


Also described here are methods for performing a procedure inside a heart. In general, the methods comprise positioning a catheter adjacent to heart tissue. The catheter may comprise a longitudinal axis, a first elongate element lumen, a second elongate element lumen, a tissue anchor lumen, and a plurality of apertures along the longitudinal axis. The plurality of apertures may comprise first elongate element apertures, second elongate element apertures, and tissue anchor apertures. The catheter may further comprise a plurality of retaining portions each between adjacent tissue anchor apertures and between adjacent first and second elongate element apertures. A first elongate element may be disposed within the first elongate element lumen and a second elongate element may be disposed within the second elongate element lumen. The plurality of retaining portions may each comprise a channel along the longitudinal axis. For each pair of adjacent first and second elongate element apertures, the first elongate element may extend out of the first elongate element lumen through the first elongate element aperture across the retaining portion transversely with respect to the longitudinal axis and towards the second elongate element aperture. The first elongate element may extend into the second elongate element aperture, loop over the second elongate element, and extend back across the retaining portion and into the first elongate element lumen. A first tissue anchor and at least a second tissue anchor may be deployed into the heart tissue. A tether may couple the first tissue anchor to at least the second tissue anchor. The second elongate element may be retracted from the second elongate element lumen to uncouple the first elongate element from the second elongate element and to open the channel for passage of the first and second tissue anchors. The uncoupled first elongate element may be tensioned. The catheter may be removed from the heart.


In some variations, the catheter may be temporarily secured to heart tissue using at least one of the first and second tissue anchor. In other variations, retracting the second elongate element may increase slack of the first elongate element. In yet other variations, retracting the second elongate element may open the channel. In some variations, the first elongate element may cross over itself. In other variations, the first elongate element may be tensioned against the second elongate element. In yet other variations, the catheter may be indirectly visualized. In some variations, an anchor delivery catheter may be advanced within the catheter.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a cross-sectional view of a heart with a catheter advanced through the aorta and into the left ventricle.



FIGS. 2A-2C are side and perspective views of an illustrative variation of a catheter and proximal hub.



FIGS. 3A-3B are proximal and distal cross-sectional views of an illustrative variation of a catheter.



FIGS. 4A-4C are detailed side views of an illustrative variation of an implant release mechanism of a catheter.



FIGS. 5A-5B are perspective views of an illustrative variation of a distal end of a catheter.



FIGS. 6A and 6C-6E are perspective views of an illustrative variation of tissue anchors and a distal end of a catheter. FIG. 6B is a schematic representation of an illustrative variation of a catheter, implant, and heart tissue.



FIGS. 7A-7E are schematic representations of a method for deploying tissue anchors to heart tissue using a catheter.



FIG. 8 is a flowchart of an illustrative variation of an implant releasing process.





DETAILED DESCRIPTION

Described here are devices, systems, and methods for detaching or decoupling an outer catheter from an implanted device during a heart procedure, such as from a subannular region of the left ventricle. Generally, the devices and systems described here are used to reshape atrio-ventricular valves or myocardium to improve hemodynamic performance. The implantation procedures are preferably transvascular, minimally invasive surgical procedures, but can also be performed with open or limited access surgical procedures.


In instances where the heart is the relevant anatomy, it may be helpful to briefly identify and describe the relevant heart anatomy. FIG. 1 is a cross-sectional depiction of a heart H having a right atrium RA, right ventricle RV, left atrium LA, and left ventricle LV. Tricuspid valve leaflets TVL are provided between the right atrium RA and the right ventricle RV, and mitral valve leaflets MVL are provided between the left atrium LA and left ventricle LV. A catheter 100 is shown being advanced in a retrograde direction through the aorta A and into the left ventricle LV. This access route is used to reach the subvalvular space 106. Retrograde, as used herein, generally refers to a direction opposite the expected flow of blood.


Catheter 100 is generally a flexible elongate catheter which may have one or more curves or bends towards its distal end to facilitate placement of the distal end 102 of the catheter 100 at a desired location. The subvalvular space, as used herein, generally includes the portion of the ventricular chamber that is bound peripherally by the ventricular wall, superiorly by the atrio-ventricular valve leaflets, and centrally by the primary chordae tendineae, and is located along the circumference of the valve annulus. The subannular groove region 104, as used herein, includes the space bordered by the inner surface of the ventricular wall, the inferior surface of valve leaflets MVL, and the third order chordae tendineae connected directly to the ventricular wall and the leaflet MVL.


The distal end 102 of catheter 100 may be configured to be positioned at an opening into the subvalvular space 106 or within the subvalvular space 106, such that subsequent devices may be passed through catheter 100 into the subvalvular space 106. Although the retrograde aortic access route may begin from a percutaneous or peripheral access site, aortic access may alternatively be achieved by an incision in the ascending aorta, descending aorta, aortic arch or iliac arteries, following surgical, thorascopic or laparoscopic access to a body cavity.


I. Devices and Systems


Described here are devices and systems for detaching or decoupling an outer catheter from an implant. For example, a decoupled outer catheter may be removed from a subannular region of the left ventricle of the heart after deployment of the implant from the outer catheter into heart tissue. For example, the outer catheters described here may be used in beating heart procedures where it may be difficult to control the position of the distal end of an anchor delivery catheter with respect to the target tissue. Generally, an outer catheter comprises a plurality of lumens and apertures along a longitudinal axis of the outer catheter. The implant may comprise one or more tissue anchors that may be advanced through a tissue anchor lumen of the outer catheter. The tissue anchors may be coupled together by a tether. A plurality of tissue anchor apertures may be arranged longitudinally at a distal portion of the outer catheter to allow the tissue anchors to be delivered out of corresponding tissue anchor apertures.


In one variation, an implant delivery system may comprise an outer catheter and an inner catheter slidable within the outer catheter. An anchor delivery catheter may be slidable within the inner catheter. Once the outer catheter has been positioned at its desired location, it need not be moved relative to heart tissue to deploy an implant (e.g., a plurality of tissue anchors). Instead, the anchor delivery catheter and/or inner catheter may be manipulated within the non-moving outer catheter to deploy the tissue anchors through a desired tissue anchor aperture. The outer catheter also permits delivery of tissue anchors with predetermined spacing and/or alignment with respect to each other. Thus, the outer catheter may reduce the risk that during a lengthy procedure with multiple anchoring sites, repositioning of the anchor delivery catheter to a new target location may dislodge the anchor delivery catheter and/or the implant from heart tissue.


After deployment of tissue anchors from the outer catheter, portions of the implant (e.g., tether) may be retained within the outer catheter until a mechanism is actuated that allows the tether to be released from the outer catheter. The devices and system discussed below comprise an implant release mechanism that allows the tissue anchors to completely separate and release from the outer catheter with minimal force and physical interference, thereby reducing the risk of damage to the system and tissue. For instance, the implant release mechanism may be operated in a manner where the mechanism does not interfere with any of a tissue anchor, tether, outer catheter, and heart tissue. The implant release mechanism may be easily operated from a hub and may utilize, but need not require, direct or indirect visualization.


One variation is illustrated in the side view of FIG. 2A. As depicted, an implant delivery system may comprise an outer catheter 202 and hub 250. A distal end of the outer catheter 202 may comprise tissue anchor apertures 204 and an atraumatic distal tip 206. The tissue anchor apertures 204 may be sized for passage of tissue anchors (not shown) delivered through the outer catheter 202. An inner catheter 210 may be disposed through at least a portion of the outer catheter 202. As described in more detail below, an outer catheter may comprise a plurality of lumens to engage with one or more other outer catheters and release one or more implants from the catheter, such as heart tissue anchors.


A hub 250 is coupled to a proximal end of the outer catheter 202. As depicted in FIGS. 2A and 2C, the hub 250 may comprise a plurality of ports including a first elongate element control port 252, a second elongate element control port 254, inner catheter port 256, and guidewire port 258. The hub may further comprise flush ports for outer catheter 202 and inner catheter 210. The first and second elongate element control ports 252, 254 may be controlled by a user to unlock the outer catheter 202 to release tissue anchors from the outer catheter 202, as described in more detail below.


Outer Catheter


A perspective view of the distal portion of outer catheter 202 is illustrated in FIG. 2B and comprises a distal tip 206 and a plurality of tissue anchor apertures 204. In some variations, the outer catheter may comprise 11 or 13 apertures. In some of these variations, two tissue anchors may be deployed out of the proximal-most aperture such that a total of 12 or 14 anchors may be deployed from a respective outer catheter. An outer catheter may comprise any number of apertures, for example, 4, 6, 7, 10, 12, 15, 16, 17, 20, 24 or more apertures. The distal portion of the outer catheter 202 as shown in FIG. 2B may comprise a curvature configured to facilitate the placement of tissue anchors in a subannular groove region. In this manner, the distal portion may more easily conform to the geometry of the atrio-ventricular valve. As discussed in further detail below, fluoroscopic visualization of radiopaque structures of the outer catheter may help position and/or align the outer catheter to a desired tissue region.


An implant release mechanism 208 may be provided between adjacent apertures 204 and include a retaining portion 212 that separates adjacent tissue anchor apertures 204. A first elongate element 214 may extend transversely relative to a longitudinal axis of the outer catheter 202 across an external surface of the outer catheter 202 to hold the retaining portion 212 in a closed configuration that promotes stability of the outer catheter 202 during delivery of an implant (e.g., tissue anchors). As will be discussed in more detail with respect to FIGS. 4A-4C and 6A-6E, an implant release mechanism is actuated such that a longitudinal channel within the retaining portion may open to allow the passage of a tether coupled to tissue anchors to be completely released from the outer catheter.


Lumens



FIG. 3A depicts a cross-sectional view of a proximal end of an illustrative variation of an outer catheter 302 as viewed from the A-A line of FIG. 2A. FIG. 3B depicts a cross-sectional view of a distal end of outer catheter 302 as viewed from the B-B line of FIG. 2A. The outer catheter 302 may include a first elongate element lumen 304 having a first elongate element 310 disposed therein and a second elongate element lumen 306 having a second elongate element 312 disposed therein. In some variations, the second elongate element lumen 306 may extend from a distal portion of an outer catheter 302 to a hub. A diameter of the second elongate element 312 may range from about 0.10 mm to about 0.30 mm and may be, for example, a 0.203 mm diameter. The first elongate element lumen 304 may extend from a distal portion of the outer catheter 302 to a hub. A diameter of the first elongate element 312 may range from about 0.10 mm to about 0.30 mm and may be, for example, a 0.254 mm diameter first elongate element 310.


A guidewire lumen 314 may be provided for a guidewire (not shown) to provide relative movement between the outer catheter 302 and guidewire. For example, the guidewire may first be advanced from the descending aorta, through the left ventricle into subvavular space behind chordae tendineae, and positioned in a subannular groove region. Then, the outer catheter 302 may be advanced over the guidewire to position the outer catheter 302 in the subannular groove region under the mitral valve. Accordingly, the guidewire may be used as a rail for outer catheter placement. Once the outer catheter 302 is advanced to a desired position, the guidewire may remain in place throughout a procedure to facilitate ease of use and safety. For example, the guidewire may function as a rail and a position locator if there is a need to remove and replace the outer catheter during the procedure. Additionally or alternatively, the guidewire may extend out of the distal end of the outer catheter and form an atraumatic tip. Alternatively, once the outer catheter 302 is advanced to a desired position, the guidewire may be withdrawn proximally from the guidewire lumen 314, and out of a guidewire port.


The guidewire lumen 314 may form a circular cross-section at a proximal end of the outer catheter 302 (FIG. 3A) and an oval cross-section at a distal end of the outer catheter 302 (FIG. 3B). In some variations, the guidewire may have a diameter in a range of about 0.20 mm to about 0.60 mm and may be, for example, 0.457 mm in diameter. The proximal and distal lumens in FIGS. 3A-3B coincide and may run the entire length of the outer catheter 302 shaft. While the cross-sectional shape of the guidewire lumen may vary across the length of the outer catheter, it should be understood that in other variations, the cross-sectional shape of the guidewire lumen may be the same across the length of the outer catheter. The cross-section of a guidewire lumen may be similar to that of a circle, oval, ellipse, square, rectangle, etc.


In some variations, one or more of the lumens may comprise a liner to reinforce the lumen or provide a friction different than that of the lumen. For example, a lumen may comprise a material such as PEBAX, and a liner may have a high friction coefficient and/or may comprise a material such as PTFE. For instance, FIGS. 3A and 3B depict a tissue anchor lumen liner 322, a first elongate element lumen liner 324, a second elongate element lumen liner 326, a guidewire lumen liner 328, and an inner catheter lumen liner 330. A tissue anchor lumen liner 322 may be provided on a surface of the tissue anchor lumen 308 and may be between the outer catheter 302 and inner catheter 330. The inner catheter 320 may be provided between the tissue anchor lumen liner 322 and the inner catheter lumen liner 330. The inner catheter lumen liner 330 may be provided on an internal surface of the inner catheter 320. First elongate element lumen liner 324 may be provided on a surface of the first elongate element lumen 304. Second elongate element lumen liner 326 may be provided on a surface of the second elongate element lumen 306. Guidewire lumen liner 328 may be provided on a surface of the guidewire lumen 314.


In some variations, the outer catheter 302 may comprise a polymer jacket 316 and/or braid reinforcement 318 to reinforce the outer catheter 302 and/or alter the flexibility of the outer catheter 302. A polymer jacket may be made, for example, from a low stiffness material in order to form a flexible catheter, while the braid reinforcement may be braided with a pitch to improve torque transmission without significantly increasing stiffness. Braid reinforcement 318 may be provided within the polymer jacket 316 in a spaced apart manner away from a lumen side of the outer catheter 302. In some variations, a distal end of the outer catheter 302 may decrease in diameter relative to the proximal end, and may be provided without braid reinforcement. Accordingly, the distal end of the outer catheter 302 may be more flexible than a proximal end of the outer catheter 302.


Inner Catheter


In some variations, an implant delivery system may comprise an inner catheter 320 slidable within a tissue anchor lumen 308 of the outer catheter 302, as shown in FIGS. 3A-3B. The inner catheter 320 may have an inner catheter lumen through which an anchor delivery catheter (not shown) having a plurality of tissue anchors that may be advanced through the tissue anchor lumen 308. In some variations, inner catheter 320 may be used to simplify positioning of one or more anchor delivery catheters with respect to deployment of tissue anchors from the outer catheter 302. For instance, inner catheter 320 may comprise a single aperture at a distal end of the inner catheter 320. This aperture may be sequentially aligned with each tissue anchor aperture of the outer catheter 302 in order to sequentially deliver anchors at each tissue site corresponding to the location of each tissue anchor aperture. That is, aligning the aperture of the inner catheter with a desired tissue anchor aperture of the outer catheter may help to facilitate the positioning of an anchor delivery catheter by ensuring that when the anchor delivery catheter is advanced into and reaches the distal end of the inner catheter, the delivery aperture(s) of the anchor delivery catheter is aligned with the desired tissue anchor aperture. A tissue anchor deployed from the anchor delivery catheter exits out of the aperture of the inner catheter 320 through an aligned tissue anchor aperture of the outer catheter 302. The inner catheter 320 may thus facilitate tissue anchor deployment through the tissue anchor apertures of outer catheter 302. Alternatively, the anchor delivery catheter itself may exit aligned apertures of the inner and outer catheters (FIGS. 7D-7E), and may, in some instances, contact the tissue into which the anchor is to be deployed. A user is assured that alignment of the inner catheter 320 relative to the outer catheter 302 also aligns an anchor delivery catheter with the outer catheter 302.


Implant Release Mechanism


An implant release mechanism as depicted in FIGS. 4A-4C and FIGS. 5A-5B may provide releasable retention of tethered tissue anchors without requiring repositioning of the outer catheter for each anchor. At least a portion of a tether may be held within a lumen of the outer catheter until actuation of the implant release mechanism. In some variations, components of the implant release mechanism may be withdrawn (e.g., elongate elements) into the outer catheter to prevent interference of the implant release mechanism with the implant and/or heart tissue. As referred to herein, an implant may comprise a plurality of tissue anchors slidably coupled by a tether.



FIG. 4A provides a detailed side view of outer catheter 400 including implant release mechanism 402 having a first elongate element lumen 404 and a second elongate element lumen 406. In FIGS. 4A-4C, outer catheter 400 is depicted as partially transparent in order to better show the elongate elements and lumens. A first elongate element 410 is disposed within the first elongate element lumen 404 and a second elongate element 412 is disposed within the second elongate element lumen 406.


The outer catheter 400 may further comprise a plurality of tissue anchor apertures 408 along a longitudinal axis of the outer catheter 400. The tissue anchor apertures 408 may open into a tissue anchor lumen of the outer catheter 400. The first and second elongate element lumens 404, 406 are provided parallel to the longitudinal axis of the outer catheter 404 on either side of the tissue anchor apertures 408.


The outer catheter 400 may include one or more first elongate element apertures 414 and second elongate element apertures 416. The first and second elongate element apertures 414, 416 open into respective first and second elongate element lumens 404, 406. The first and second elongate element apertures 414, 416 may be any size and shape that allows the first elongate element 410 to exit and enter the first and second elongate element apertures 414, 416. Adjacent first and second elongate element apertures 414, 416 in the transverse direction with respect to the longitudinal axis are referred to as an elongate element aperture pair.


A retaining portion 418 may be provided between adjacent tissue anchor apertures 408 and an elongate element aperture pair. The retaining portion 418 may comprise a polymer wall structure that separates adjacent tissue anchor apertures 408 and first and second elongate element apertures 414, 416. The retaining portion 418 may comprise a channel 420 that is adapted to be in a locked, closed configuration (FIGS. 4A, 5A-5B) and an unlocked, open configuration (FIGS. 4B-4C). In some variations, a channel width may be from about 0.5 mm to about 0.8 mm in the open configuration. In some variations, a channel width may be 0.0 mm to about 0.4 mm in the closed configuration. Each of the channels 420 may extend along the longitudinal axis of the outer catheter 400. Edges of the channel 420 move away from each other in the open configuration to form an aperture between the edges.


As shown in FIGS. 4A-4B, the first elongate element 410 may be releasably coupled to the second elongate element 412. For each pair adjacent first and second elongate element apertures 414, 416, the first elongate element 410 may extend out of the first elongate element lumen 404 through the first elongate element aperture 414, and extend across the retaining portion 418 in a transverse direction with respect to the longitudinal axis of the outer catheter 400. The first elongate element 410 may cross over an external surface of the outer catheter 400 and over the closed channel 420 towards the second elongate element aperture 416. The external surface is, for example, an exterior of the outer catheter 400.


The first elongate element 410 may extend into the second elongate element aperture 416 and loop 422 over the second elongate element 412 to couple the first and second elongate elements 410, 412 to each other. The first elongate element 410 may extend out of the second elongate element aperture 416 and extend back across over the external surface of the outer catheter 400, the channel 420, and retaining portion 418. The first elongate element 410 may extend into the first elongate element aperture 414 and back into the first elongate element lumen 404.


A locked configuration of the implant release mechanism refers herein to the configuration shown in FIG. 4A where first elongate element 410 is looped over the second elongate element 412. If the channel 420 is open in the locked configuration, a tether of the implant will be retained by the first elongate element 410 to maintain the connection between the outer catheter 400 and the implant. However, when the first elongate element 410 is looped and tensioned against the second elongate element 416, the channel 420 is provided in the closed configuration.


In some variations, the first elongate element 410 extending between the first and second elongate element apertures 414, 416 (over the retaining portion 418) crosses over or intertwines itself, as shown in FIGS. 5A-5B.


In some variations, the first elongate element 410 may be formed of any material that may be looped and tensioned around the second elongate element 412. In some instances, the first elongate element 410 may be a fiber cable such as a flexible, twistable, and/or lubricious cable. In some variations, the first elongate element 410 may be fixed to a distal end of the outer catheter 400 (not shown). In some instances, a distal end of the first elongate element 410 may be terminated in the first elongate element lumen 404 by a knot or any other suitable method such that the first elongate element 410 is fixed and remains secured to the outer catheter 400 when a proximal end of the first elongate element 410 is retracted from the first elongate element lumen 404. This allows the tension of the first elongate element 410 to be controlled when the first elongate element 410 is releasably coupled from the second elongate element 412.


The second elongate element 412 may be formed of any material that may hold its shape as it is looped by and coupled to the first elongate element 410. In some instances, the second elongate element 412 may be a wire such as a metal wire or metal rod, a wire thread, or ribbon formed from metal, polymer, or combination thereof.


A transition of the implant release mechanism 402 from the locked and closed configuration to an unlocked and open configuration will be described with respect to FIGS. 4B-4C. In FIG. 4B, the second elongate element 412 (not shown) is retracted proximally from the second elongate element lumen 406 such that the first elongate element 410 is uncoupled from the second elongate element 412, thereby unlocking the implant release mechanism 402. The loop 422 of the first elongate element 410 is no longer coupled to the second elongate element 412 and may move freely out of the second elongate aperture 406. Retraction of the second elongate element 412 also increases slack of the first elongate element 410 and which may permit the channel 420 to be opened. The order of release of the implant release mechanisms 402 begins with the distal-most mechanism and finishes with the most proximal mechanism. The open channel 420 may be configured for passage of a tether coupled to a lumen side of the retaining portion 418.


In FIG. 4C, the first elongate element 410 is retracted proximally to increase tension and/or remove slack in the first elongate element 410. When the first elongate element 410 is retracted 424, the first elongate element 410 is withdrawn into the first elongate element lumen 404 such that the first elongate element 410 is unable to snag against a tissue anchor, heart tissue or any other structure. Retraction of the first and second elongate elements 410, 412 from respective first and second elongate element lumens 404, 406 may be through a first and second elongate element control, as shown in FIG. 2C.


It should be noted that once the second elongate element 412 is retracted, a tether may be released from the outer catheter 400 through the open channel 420 (FIG. 4B) prior to tensioning the first elongate element (FIG. 4C).



FIGS. 5A-5B are perspective views of a distal end of an outer catheter 502. A distal end of the outer catheter 502 may comprise a plurality of tissue anchor apertures 504 separated by a retaining portion 506. The retaining portion 506 as shown in FIG. 5A may include a first elongate element aperture 508 and a first elongate element 510. FIG. 5B illustrates a perspective view of the second elongate element aperture 512 and second elongate element 514. For each retaining portion 506, the first elongate element 510 may extend out of the first elongate element aperture 508, and extend across the retaining portion 506 in a transverse direction with respect to the longitudinal axis of the outer catheter 502. The first elongate element 510 may cross over an external surface of the outer catheter 502 towards the second elongate element aperture 512.


The first elongate element 510 may extend into the second elongate element aperture 512 and loop over the second elongate element 514 to couple the first and second elongate elements 510, 514 to each other. The first elongate element 510 may extend out of the second elongate element aperture 512 and extend back across over the external surface of the outer catheter 502 and over retaining portion 506. The first elongate element 510 may extend into the first elongate element aperture 508. The first elongate element 510 extending between the first and second elongate element apertures 508, 512 (over the retaining portion 506) may cross over or intertwine. In this closed configuration of the retaining portion 506, the first elongate element 510 may be looped around the second elongate element 514 to close the retaining portion 506.


The size and shape of the retaining portions described above are not particularly limited. In some variations, a retaining portion may comprise an aperture having substantially the same width as the tissue anchor aperture such that outer catheter may comprise a single continuous tissue anchor aperture. In these variations, the first elongate element extending across the retaining portion may serve as a physical barrier to secure a portion of a tether to the outer catheter.


In some variations, the first elongate element may extend across the retaining portion at an angle with respect to the longitudinal axis of the outer catheter, for example, in a shoelace pattern. Alternatively, an outer wall structure of the retaining portion and the first elongate element may together physically retain a portion of a tether to the outer catheter until actuation of the implant release mechanism.


In other variations, an implant release mechanism may comprise transverse lumens extending through (i.e., within the thickness of) the retaining portions. A transverse lumen may open into both the first and second elongate element lumens to provide a path for the first elongate element to releasably couple to the second elongate element in the second elongate element lumen. The first elongate element may loop over the second elongate element in a similar manner as described above. In this manner, the first elongate element need not travel over an exterior of the outer catheter to loop and secure to the second elongate element. Furthermore, in these variations, first and second elongate element apertures may be removed such that a distal end of the first and second elongate element lumens are not directly open to fluid and/or tissue within a body cavity such as the heart.


Each retaining portion may comprise at least one transverse lumen. In variations where the retaining portion comprises one transverse lumen, the first elongate element may cross over or intertwine itself within the transverse lumen. In variations where the retaining portion comprises two transverse lumens, the first elongate element may extend through a first transverse lumen, couple to the second elongate element in the second elongate element lumen, and then may extend through a second transverse lumen and back into the first elongate element lumen. In some variations, the transverse lumens need not be perpendicular to the first and second elongate element lumens and may be formed at an angle with respect to the longitudinal axis of the outer catheter. In some instances, the transverse lumens may form an “X” shape to allow the first elongate element to cross over or intertwine itself.


Tissue Anchor


Tissue anchors may be secured to tissue (e.g., the heart) using the outer catheters described to releasably retain a tether coupled to the tissue anchors. “Anchors,” as described herein, are defined to mean any fasteners. In some variations, one or more tissue anchors may be loaded into an anchor delivery catheter. An anchor delivery catheter may be advanced through the lumen of an outer catheter described herein and a first tissue anchor may be deployed into heart tissue. The first tissue anchor may be coupled or secured to a tether. The remaining tissue anchors may be slidably coupled to the tether. In some variations, the tether may be in the form of a cable or wire. In this way, after the first tissue anchor is secured to heart tissue, the tether will remain coupled to the first tissue anchor.


While the tether may be used as a track or monorail for the advancement of additional anchor delivery catheters thereover, the tether is also a component of the tissue anchor structure that interconnects the multiple tissue anchors. A portion of the tether may facilitate the tightening of a valve and remain in the body with the tissue anchors after the anchor delivery system is removed from the body. For instance, when pulled proximally while restraining the position of the proximal tissue anchor, the tether may be used to cinch or reduce the circumference of the atrio-ventricular valve annulus or the annular tissue.


In FIG. 6A, a distal end of outer catheter 602 is depicted and includes a plurality of tissue anchor apertures 604, retaining portions 606, first elongate element apertures 608, second elongate element apertures 612, second elongate element 614, and radiopaque structures 624. For the sake of clarity, heart tissue is not illustrated in FIGS. 6A and 6C-6E. A first tissue anchor 616 is coupled to a second tissue anchor 620 by a tether 618. The tether 618 may be coupled to the first tissue anchor 616 by a knot 626 (FIG. 6B). The attachment of a tissue anchor and tether may be achieved via a knot, weld, adhesive, or by any other suitable attachment mechanism. Optionally, a force distributing member (FDM) or spacer may be provided with varying lengths between tissue anchors. For example, an FDM 622 of a first length may be coupled between the first and second tissue anchors 616, 620, and between the proximal most pair of tissue anchors. An FDM 628 of a second length longer than the first length may be coupled between adjacent intermediate tissue anchors.


The first tissue anchor 616 may be deployed from a tissue anchor lumen through the distal-most tissue anchor aperture 604. The second tissue anchor 620 may be deployed through the next distal-most tissue anchor aperture 604. A portion of the tether 618 is retained on a lumen side of the retaining portion 606. As shown in FIG. 6B, the tether 618 coupled to the first tissue anchor 616 may be slidably coupled to the spacer 626, and may be routed on a lumen side of the retaining portion 606, and then slidably coupled to the spacer 628. This pattern may continue until the most proximal tissue anchor aperture where two tissue anchors are positioned without routing on a lumen side of the retaining portion 616.


As shown in FIG. 6B, each of the tissue anchors may be deployed and secured to heart tissue 650 while the retaining portions 606 are in the closed configuration. At this point, the tissue anchors may be coupled to heart tissue 650 and outer catheter 602. Since the tether 618 is routed on a lumen side of each of the retaining portions 606, the outer catheter 602 cannot be removed from the body without damage to one or more of the heart tissue 650, tissue anchors, and outer catheter 602.


The retaining portions 606 may transition from a closed configuration to an open configuration as explained using FIGS. 6C-6E. FIG. 6C is a perspective view of a distal end of outer catheter 602 after second elongate element (not shown) has been retracted from the second elongate lumen, thus opening the retaining portion 606 and allowing passage of the tether 618 through a channel in the retaining portion 606. For instance, the first elongate element 610 may move freely, as shown in FIG. 6D, and possibly interfere with the tissue anchor or other structures. Therefore, as shown in FIG. 6E, the first elongate element 610 may be retracted and withdrawn into the first elongate element aperture 608. Consequently, the first elongate element 610 does not interfere with any of a tissue anchor 616, tether 618, heart tissue 650, and outer catheter 602 as the outer catheter 602 is separated from the tether 618 and the tissue anchors 616, 620.


In some variations, the tissue anchors may comprise C-shaped or semicircular hooks, curved hooks of other shapes, straight hooks, barbed hooks, clips of any kind, T-tags, or any other suitable fastener(s). In some variations, tissue anchors may comprise two tips that curve in opposite directions upon deployment, forming two intersecting semi-circles, circles, ovals, helices or the like. In some variations, the tips may be sharpened or beveled.


In some variations, the tissue anchors are self-deforming. By “self-deforming” it is meant that the tissue anchors are biased to change from a first undeployed shape to a second deployed shape upon release of the tissue anchors from an outer catheter. Such self-deforming tissue anchors may change shape as they are released from a housing or deployed from a lumen or opening to enter annular tissue, and secure themselves to the tissue. Self-deforming anchors may be made of any suitable material such as spring stainless steel, or super-elastic or shape-memory material like nickel-titanium alloy (e.g., Nitinol). In some variations, anchors may comprise one or more bioactive agents, including biodegradable metals and, polymers.


In some variations, the tether may be made from any suitable or desirable biocompatible material. The tether may be braided or not braided, woven or not woven, reinforced or impregnated with additional materials, or may be made of a single material or a combination of materials. For example, the tether may be made from a suture material (e.g., absorbable suture materials such as polyglycolic acid and polydioxanone, natural fibers such as silk, and artificial fibers such as ultra-high molecular weight polyethylene (UHMW PE), polypropylene, polyester, polyester impregnated with polytetrafluoroethylene, nylon, polyetheretherketone, etc.), a metal (absorbable or non-absorbable), a metal alloy (e.g., stainless steel), a shape memory material, such as a shape memory alloy (e.g., a nickel titanium alloy), other biocompatible material, or any combination thereof.


Hub


A perspective view of the hub 250 is shown in FIG. 2C and may include a first elongate element control port 252, a second elongate element control port 254, an inner catheter port 256, and a guidewire port 258. The control ports 252, 254 may be manipulated to retract and/or withdraw respective first and second elongate elements from their lumens. In one variation, a knob of the control ports 252, 254 may be unscrewed to allow a user to retract at least a portion of the elongate elements out of the control ports 252, 254. In some variations, retracting the first elongate element through the control port 252 may increase the tension of the first elongate element when a distal end of the first elongate element is fixed to a distal end of the outer catheter.


Radiopaque Structures


A radiopaque structure may be located between the plurality of apertures opposite the apertures. The radiopaque structures may be visualized indirectly, such as through fluoroscopy. Accordingly, the radiopaque structures 624 (e.g., FIG. 6B) may facilitate the positioning of a delivery catheter with respect to outer catheter 602. In some variations, the radiopaque structures may be radiopaque markers. Indirect visualization may be utilized throughout the procedures described to confirm catheter positioning relative to heart structures.


II. Methods


The catheters described herein may be useful for detaching or decoupling an outer catheter from an implant. For example, the methods discussed below may allow removal of an outer catheter from a subannular region of the left ventricle of the heart. Generally, removal of an outer catheter may comprise releasing an implant (e.g., tissue anchors) from the outer catheter. The methods may generally involve positioning an outer catheter adjacent to heart tissue, advancing an anchor delivery catheter within the outer catheter, deploying tissue anchors into heart tissue, releasing the tissue anchors from the outer catheter, and removing the outer catheter from the heart. For instance, an implant release mechanism may be actuated to open a passage for release of the tissue anchors, as described in more detail below.


One variation of a method to detach or decouple an outer catheter from an implant is illustrated in the flowchart 800 of FIG. 8 and may comprise positioning an outer catheter adjacent to heart tissue 802. An inner catheter may be advanced through a lumen of the outer catheter to align with a desired aperture in the outer catheter. An anchor delivery catheter may be advanced through the inner and outer catheter 804. An implant may be deployed into a desired location into heart tissue 806. The implant may comprise a plurality of tissue anchors provided with a predetermined spacing. The implant may further comprise a tether to slidably couple adjacent tissue anchors. First and second elongate elements of an implant release mechanism may be uncoupled 808. For instance, a second elongate element may be retracted from a second elongate element lumen of the outer catheter to uncouple the first elongate element from the second elongate element and thereby open the channel for passage of the implant therethrough. The uncoupled first elongate element 810 may be tensioned to withdraw the first elongate element into the outer catheter. The outer catheter may be removed from the heart 812 with the implant secured to heart tissue. Variations of the methods are further described with respect to FIGS. 7A-7E and 6C-6D.



FIGS. 7A-7E illustrates a heart from an inferior perspective looking in a superior direction for a subannular groove region. FIG. 7A shows a left side of the heart 700 having myocardium 706, endocardium 704, left ventricle (LV) chamber 702, and aortic outflow tract and aortic valve 708. In FIG. 7B, a guide catheter 710 having a distal opening 712 is inserted across the aortic valve 708 and placed tangent to the endocardium 704. After guide catheter 710 has been positioned at the desired location in the subannular groove region, a guidewire (not shown) may be advanced through the lumen of guide catheter 710. The guidewire may be advanced beyond the distal end 712 of guide catheter 710 and positioned in the subannular groove region.


In FIG. 7C, outer catheter 720 may be advanced through guide catheter 710 over the guidewire. The radiopaque structures may be used to position the outer catheter 720 in a desired position to direct placement of tissue anchors into the myocardium 706 of the heart 700. In some variations, outer catheter 720 may be pre-shaped or pre-formed at its distal end to have a curved shape, as illustrated in FIG. 2B. In this manner, the outer catheter 720 may more easily conform to the geometry of the atrio-ventricular valve. It should also be understood that any of the catheters or guidewires described here may be pre-shaped or pre-formed to include any number of suitable curves, angles or configurations. The guidewires and/or catheters described here may also be steerable.


Once the outer catheter 720 is positioned against or near the endocardium 704 through the guide catheter 710, the guidewire may be withdrawn proximally and the outer catheter 720 may direct the placement of an implant, such as heart tissue anchors, into myocardium 706 of the left ventricle 702. For instance, the tissue anchors may be deployed to a depth of about 6 mm. The outer catheter 720 may comprise a plurality of tissue anchor apertures 722 and radiopaque structures 724. The outer catheter 720 may be indirectly visualized through the radiopaque structures 724.


As shown in FIG. 7D, an anchor delivery catheter 730 may be advanced through the lumen of outer catheter 720 such that a distal tip 732 of the anchor delivery catheter 730 may exit a tissue anchor aperture 722 and contact the endocardium 704. Further advancement of the delivery catheter 730 may cause the distal tip 732 to penetrate the endocardium 704 to a desired depth. In some variations, the anchor delivery catheter 730 remains within outer catheter 720, while a tissue anchor is deployed through the tissue anchor aperture 722.



FIG. 7E depicts tissue anchors 740 being deployed and secured into endocardium 704. A first tissue anchor completed to a tether 742 may be deployed into the myocardium 706 at a predetermined depth from a first tissue anchor aperture 722. The anchor delivery catheter 730 may then be withdrawn proximally from the outer catheter 720. While maintaining the existing position of the outer catheter 720 about the subannular groove region, an inner catheter (not shown) of the outer catheter 720 may be repositioned at the second distal-most tissue anchor aperture 722.


A second anchor delivery catheter 730 may then be advanced over the tether 742 through the lumen of the catheter 730. After the second anchor delivery catheter 730 has been advanced over the tether 742 through the lumen of the outer catheter 720, a second tissue anchor 744 may be deployed into the myocardium 706 from a second tissue anchor aperture 722. This process may continue for each of the tissue anchor apertures 722 of outer catheter 720.



FIG. 7E illustrates the anchor delivery catheter 730 extending out of a third tissue anchor aperture 722 prior to deploying a third tissue anchor. It should be noted that the tether 742 may be routed into a tissue anchor lumen of the outer catheter 720 between adjacent tissue anchor apertures 722. As the delivery catheter 730 deploys the tissue anchors 740 into the myocardium 706, the tether 742 may be retained by an implant release mechanism provided between adjacent tissue anchor apertures, thereby temporarily securing the outer catheter 720 to the heart 700 and maintaining its location with respect to the heart. In other words, the process of delivering tissue anchors into heart tissue may also indirectly attach the outer catheter 720 to the heart tissue due to the tether 742 being routed on a lumen side of the outer catheter 720 between adjacent tissue anchor apertures 722.


In some variations, delivery and deployment of tissue anchors may be achieved by removing and reloading the same anchor delivery catheter 730. In other variations, the anchor delivery catheter may be loaded with a plurality of tissue anchors and does not need to be withdrawn from the outer catheter 720 to deliver subsequent tissue anchors.


It should be appreciated that one or more tissue anchors 740 may be deployed into the annulus directly, while other tissue anchors may be secured to other tissue in the vicinity of the subannular groove region. Tissue anchors 740 may be deployed from the anchor delivery catheter 730 and outer catheter 720 in any suitable fashion, including but not limited to a push-pull wire, using a plunger, or other suitable actuation technique.


Turning back to FIGS. 6C-6D, a second elongate element may be retracted proximally from the second elongate lumen of outer catheter 602 to uncouple the first elongate element 610 from the second elongate element and increase the slack of the first elongate element 610. A channel of the implant release mechanism (e.g., retaining portion 606) is thus opened for passage of the tether 618 between the first and second tissue anchor apertures 604.


Once the second elongate element is retracted, the uncoupled first elongate element 610 may be tensioned to withdraw the first elongate element 610 into the first elongate element lumen of the outer catheter 602, as shown in FIG. 6E, thereby preventing the first elongate element 610 from snagging or interfering with the tissue anchors 616, tether 618, outer catheter 602, and heart tissue 650. The tether 618 is fully free to come out of and separate from the outer catheter 602 to allow the outer catheter 602 to be withdrawn and removed from the heart. In some variations, as the outer catheter is removed from the heart, the tether 618 may pass through a channel of the retaining portion 606. In some variations, the tether 618 may be tensioned to help release and/or separate the tether from the outer catheter without disrupting the implanted anchors.


It should be noted that prior to introducing the outer catheter into a body cavity, the first elongate element may be crossed over itself and coupled to a second elongate element, as shown in FIG. 5B. In this manner, the first elongate element is tensioned against the second elongate element to close a channel of a retaining portion.


The procedures described above represents variations that may be used to treat the annular tissue of the mitral valve. In other variations, other tissues or structures of the heart and vasculature can also be treated, including but not limited to the subvalvular apparatus, septal structures, and the myocardium. In still other variations, one or more cinchable implants may be deployed in non-cardiac tissues or structures, for example, to treat gastrointestinal disorders such as obesity, genitourinary conditions such as incontinence, or to perform cosmetic and reconstructive procedures.


While the inventive devices, systems, and methods have been described in some detail by way of illustration, such illustration is for purposes of clarity of understanding only. It will be readily apparent to those of ordinary skill in the art in light of the teachings herein that certain changes and modifications may be made thereto without departing from the spirit and scope of the appended claims.

Claims
  • 1. A catheter comprising: a plurality of apertures, the plurality of apertures including at least a first elongate element aperture and a second elongate element aperture adjacent to each other;a first elongate element within a first elongate element lumen; anda second elongate element within a second elongate element lumen,wherein for the pair of adjacent first and second elongate element apertures, the first elongate element extends out of the first elongate element lumen through the first elongate element aperture into the second elongate element aperture, loops over the second elongate element, and extends back into the first elongate element lumen.
  • 2. The catheter of claim 1, wherein the first elongate element is releasably coupled to the second elongate element.
  • 3. The catheter of claim 1, wherein the first elongate element extending between the first and second elongate element apertures crosses over itself.
  • 4. The catheter of claim 1, wherein the first elongate element is configured to be retracted from the first elongate lumen via a first elongate element control and the second elongate element is configured to be retracted from the second elongate lumen via a second elongate element control.
  • 5. The catheter of claim 4, wherein retracting the first elongate element from the first elongate lumen tensions the first elongate element.
  • 6. The catheter of claim 1, further comprising a retaining portion between the pair of adjacent first and second elongate element apertures.
  • 7. The catheter of claim 6, wherein the retaining portion comprises a channel along a longitudinal axis.
  • 8. The catheter of claim 7, wherein the channel is adapted to be in at least one of a closed configuration and an open configuration.
  • 9. The catheter of claim 8, wherein the channel is adapted to be in the closed configuration when the first elongate element is looped and tensioned against the second elongate element.
  • 10. The catheter of claim 8, wherein the channel is adapted to be in the open configuration when the first elongate element is uncoupled from the second elongate element.
  • 11. The catheter of claim 1, wherein the plurality of apertures are configured for passage of a plurality of tissue anchors.
  • 12. The catheter of claim 1, further comprising at least one radiopaque structure located between the plurality of apertures.
  • 13. A method for performing a procedure inside a heart comprising: positioning a catheter adjacent to heart tissue, wherein the catheter comprises a plurality of apertures including at least a first elongate element aperture and a second elongate element aperture adjacent to each other, a first elongate element within a first elongate element lumen, a second elongate element within a second elongate element lumen,wherein for the pair of adjacent first and second elongate element apertures, the first elongate element extends out of the first elongate element lumen through the first elongate element aperture into the second elongate element aperture, loops over the second elongate element, and extends back into the first elongate element lumen;deploying a first tissue anchor and at least a second tissue anchor into the heart tissue, wherein a tether couples the first tissue anchor to at least the second tissue anchor; andretracting the second elongate element from the second elongate element lumen to uncouple the first elongate element from the second elongate element and to open a channel for passage of the first and second tissue anchors, wherein the catheter comprises a retaining portion including the channel between the pair of adjacent first and second elongate element aperture.
  • 14. The method of claim 13, wherein retracting the second elongate element increases a slack of the first elongate element.
  • 15. The method of claim 13, further comprising crossing the first elongate element over itself.
  • 16. The method of claim 13, further comprising tensioning the first elongate element against the second elongate element.
  • 17. The method of claim 13, further comprising tensioning the uncoupled first elongate element to remove a slack in the first elongate element.
  • 18. The method of claim 13, further comprising indirectly visualizing the catheter.
  • 19. The method of claim 13, further comprising advancing an anchor delivery catheter within the catheter.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/572,757, having a 371(c) filing date of Nov. 8, 2017, now issued U.S. Pat. No. 10,980,973, which is a U.S. National Phase Application under 35 U.S.C. § 371 of International Application No. PCT/US2016/032220, filed May 12, 2016, which designated the United States, which claims priority to U.S. Provisional Application Ser. No. 62/160,595, filed on May 12, 2015, each of which is hereby incorporated by reference in its entirety.

US Referenced Citations (450)
Number Name Date Kind
2108206 Sidney Feb 1938 A
3598576 Moore et al. Aug 1971 A
3656185 Carpentier Apr 1972 A
3727614 Kniazuk Apr 1973 A
3773034 Burns et al. Nov 1973 A
3958576 Komiya May 1976 A
3961419 Schwartz Jun 1976 A
3976079 Samuels et al. Aug 1976 A
4014492 Rothfuss Mar 1977 A
4034473 May Jul 1977 A
4042979 Angell Aug 1977 A
4043504 Hueil et al. Aug 1977 A
4053979 Tuthill et al. Oct 1977 A
4055861 Carpentier et al. Nov 1977 A
4069825 Akiyama Jan 1978 A
4290151 Massana Sep 1981 A
4384406 Tischlinger May 1983 A
4445892 Hussein et al. May 1984 A
4489446 Reed Dec 1984 A
4494542 Lee Jan 1985 A
4619247 Inoue et al. Oct 1986 A
4700250 Kuriyama Oct 1987 A
4705040 Mueller et al. Nov 1987 A
4726371 Gibbens Feb 1988 A
4758221 Jureidini Jul 1988 A
4784133 Mackin Nov 1988 A
4798594 Hillstead Jan 1989 A
4845851 Warthen Jul 1989 A
4848341 Ahmad Jul 1989 A
4850354 McGurk-Burleson et al. Jul 1989 A
4961738 Mackin Oct 1990 A
4969893 Swor Nov 1990 A
4976710 Mackin Dec 1990 A
5053047 Yoon Oct 1991 A
5064431 Gilbertson et al. Nov 1991 A
5078731 Hayhurst Jan 1992 A
5084058 Li Jan 1992 A
5103804 Abele et al. Apr 1992 A
5108368 Hammerslag et al. Apr 1992 A
5133723 Li et al. Jul 1992 A
5221255 Mahurkar et al. Jun 1993 A
5221269 Miller et al. Jun 1993 A
5242456 Nash et al. Sep 1993 A
5242457 Akopov et al. Sep 1993 A
5257975 Foshee Nov 1993 A
5306296 Wright et al. Apr 1994 A
5312341 Turi May 1994 A
5324298 Phillips et al. Jun 1994 A
5346500 Suchart Sep 1994 A
5358479 Wilson Oct 1994 A
5358514 Schulman et al. Oct 1994 A
5364407 Poll Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5368591 Lennox et al. Nov 1994 A
5383905 Golds et al. Jan 1995 A
5395316 Martin Mar 1995 A
5409483 Campbell et al. Apr 1995 A
5409499 Yi Apr 1995 A
5417700 Egan May 1995 A
5423837 Mericle et al. Jun 1995 A
5437680 Yoon Aug 1995 A
5439470 Li Aug 1995 A
5450860 O'Connor Sep 1995 A
5452513 Zinnbauer et al. Sep 1995 A
5474572 Hayhurst Dec 1995 A
5507760 Wynne et al. Apr 1996 A
5520702 Sauer et al. May 1996 A
5522873 Jackman et al. Jun 1996 A
5524630 Crowley Jun 1996 A
5527323 Jervis et al. Jun 1996 A
5531686 Lundquist et al. Jul 1996 A
5531763 Mastri et al. Jul 1996 A
5545134 Hilaire et al. Aug 1996 A
5545168 Burke Aug 1996 A
5565122 Zinnbauer et al. Oct 1996 A
5571215 Sterman et al. Nov 1996 A
5591194 Berthiaume Jan 1997 A
5626590 Wilk May 1997 A
5626614 Hart May 1997 A
5630824 Hart May 1997 A
5643289 Sauer et al. Jul 1997 A
5669917 Sauer et al. Sep 1997 A
5674279 Wright et al. Oct 1997 A
5690655 Hart et al. Nov 1997 A
5709695 Northrup, III Jan 1998 A
5713950 Cox Feb 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5718725 Sterman et al. Feb 1998 A
5725542 Yoon Mar 1998 A
5735290 Sterman et al. Apr 1998 A
5741260 Songer et al. Apr 1998 A
5741301 Pagedas Apr 1998 A
5752518 McGee et al. May 1998 A
5752964 Mericle May 1998 A
5752966 Chang May 1998 A
5755730 Swain et al. May 1998 A
5766240 Johnson Jun 1998 A
5769812 Stevens et al. Jun 1998 A
5782861 Cragg et al. Jul 1998 A
5810848 Hayhurst Sep 1998 A
5810853 Yoon Sep 1998 A
5817107 Schaller Oct 1998 A
5827171 Dobak, III et al. Oct 1998 A
5843169 Taheri Dec 1998 A
5848969 Panescu et al. Dec 1998 A
5860992 Daniel et al. Jan 1999 A
5860993 Thompson et al. Jan 1999 A
5868733 Ockuly et al. Feb 1999 A
5879371 Gardiner et al. Mar 1999 A
5885238 Stevens et al. Mar 1999 A
5888240 Carpentier et al. Mar 1999 A
5902321 Caspari et al. May 1999 A
5904651 Swanson et al. May 1999 A
5906579 Vander Salm et al. May 1999 A
5911717 Jacobsen et al. Jun 1999 A
5919207 Taheri Jul 1999 A
5919208 Valenti Jul 1999 A
5935149 Ek Aug 1999 A
5947983 Solar et al. Sep 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5961539 Northrup, III et al. Oct 1999 A
5972004 Williamson, IV et al. Oct 1999 A
5984933 Yoon Nov 1999 A
5989284 Laufer Nov 1999 A
5991650 Swanson et al. Nov 1999 A
6010531 Donlon et al. Jan 2000 A
6015428 Pagedas Jan 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6050936 Schweich, Jr. et al. Apr 2000 A
6056743 Ellis et al. May 2000 A
6059715 Schweich, Jr. et al. May 2000 A
6066160 Colvin et al. May 2000 A
6074401 Gardiner et al. Jun 2000 A
6077214 Mortier et al. Jun 2000 A
6077989 Kandel et al. Jun 2000 A
6099553 Hart et al. Aug 2000 A
6102945 Campbell Aug 2000 A
6125852 Stevens et al. Oct 2000 A
6149658 Gardiner et al. Nov 2000 A
6152934 Harper et al. Nov 2000 A
6162168 Schweich, Jr. et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6171329 Shaw et al. Jan 2001 B1
6183469 Thapliyal et al. Feb 2001 B1
6197017 Brock et al. Mar 2001 B1
6203531 Ockuly et al. Mar 2001 B1
6221084 Fleenor Apr 2001 B1
6228055 Foerster et al. May 2001 B1
6228096 Marchand May 2001 B1
6250308 Cox Jun 2001 B1
6254620 Koh et al. Jul 2001 B1
6258118 Baum et al. Jul 2001 B1
6260552 Mortier et al. Jul 2001 B1
6269819 Oz et al. Aug 2001 B1
6283993 Cosgrove et al. Sep 2001 B1
6306149 Meade Oct 2001 B1
6312447 Grimes Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6332893 Mortier et al. Dec 2001 B1
6355030 Aldrich et al. Mar 2002 B1
6378289 Trudeau et al. Apr 2002 B1
6391048 Ginn et al. May 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6409743 Fenton, Jr. Jun 2002 B1
6423088 Fenton, Jr. Jul 2002 B1
6432123 Schwartz et al. Aug 2002 B2
6461327 Addis et al. Oct 2002 B1
6491689 Ellis et al. Dec 2002 B1
6514265 Ho et al. Feb 2003 B2
6524328 Levinson Feb 2003 B2
6524338 Gundry Feb 2003 B1
6533753 Haarstad et al. Mar 2003 B1
6551332 Nguyen et al. Apr 2003 B1
6575971 Hauck et al. Jun 2003 B2
6575987 Gellman et al. Jun 2003 B2
6589160 Schweich, Jr. et al. Jul 2003 B2
6602288 Cosgrove et al. Aug 2003 B1
6602289 Colvin et al. Aug 2003 B1
6607541 Gardiner et al. Aug 2003 B1
6613059 Schaller et al. Sep 2003 B2
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6629534 St. Goar et al. Oct 2003 B1
6641593 Schaller et al. Nov 2003 B1
6648903 Pierson, III Nov 2003 B1
6651671 Donlon et al. Nov 2003 B1
6655386 Makower et al. Dec 2003 B1
6669687 Saadat Dec 2003 B1
6676702 Mathis Jan 2004 B2
6689164 Seguin Feb 2004 B1
6699263 Cope Mar 2004 B2
6702826 Liddicoat et al. Mar 2004 B2
6716243 Colvin et al. Apr 2004 B1
6718985 Hlavka et al. Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6723107 Skiba et al. Apr 2004 B1
6733509 Nobles et al. May 2004 B2
6746457 Dana et al. Jun 2004 B2
6749622 McGuckin, Jr. et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6790231 Liddicoat et al. Sep 2004 B2
6793618 Schweich, Jr. et al. Sep 2004 B2
6802851 Jones et al. Oct 2004 B2
6811560 Jones et al. Nov 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6875224 Grimes Apr 2005 B2
6908424 Mortier et al. Jun 2005 B2
6923818 Muramatsu et al. Aug 2005 B2
6932792 St. Goar et al. Aug 2005 B1
6951557 Ellis et al. Oct 2005 B2
6986775 Morales et al. Jan 2006 B2
6991643 Saadat Jan 2006 B2
6997931 Sauer et al. Feb 2006 B2
7004958 Adams et al. Feb 2006 B2
7037334 Hlavka et al. May 2006 B1
7044957 Foerster et al. May 2006 B2
7048754 Martin et al. May 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7166127 Spence et al. Jan 2007 B2
7186262 Saadat Mar 2007 B2
7186264 Liddicoat et al. Mar 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7235086 Sauer et al. Jun 2007 B2
7241310 Taylor et al. Jul 2007 B2
7326231 Phillips et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7344544 Bender et al. Mar 2008 B2
7452325 Schaller Nov 2008 B2
7534204 Starksen et al. May 2009 B2
7588582 Starksen et al. Sep 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7655040 Douk et al. Feb 2010 B2
7666193 Starksen et al. Feb 2010 B2
7727247 Kimura et al. Jun 2010 B2
7753858 Starksen et al. Jul 2010 B2
7753922 Starksen Jul 2010 B2
7753924 Starksen et al. Jul 2010 B2
7758637 Starksen et al. Jul 2010 B2
7766812 Schroeder et al. Aug 2010 B2
7832406 Ellis et al. Nov 2010 B2
7850600 Piskun Dec 2010 B1
7883538 To et al. Feb 2011 B2
7918787 Saadat Apr 2011 B2
7922762 Starksen Apr 2011 B2
7993368 Gambale et al. Aug 2011 B2
8066766 To et al. Nov 2011 B2
8287555 Starksen et al. Oct 2012 B2
8287557 To et al. Oct 2012 B2
8343173 Starksen et al. Jan 2013 B2
8641727 Starksen et al. Feb 2014 B2
8790367 Nguyen et al. Jul 2014 B2
9072513 To et al. Jul 2015 B2
9226825 Starksen et al. Jan 2016 B2
9468528 Starksen et al. Oct 2016 B2
9706996 Nguyen et al. Jul 2017 B2
9949829 Starksen et al. Apr 2018 B2
10092402 Starksen et al. Oct 2018 B2
10542987 Nguyen et al. Jan 2020 B2
10624741 Starksen et al. Apr 2020 B2
10980973 Nguyen et al. Apr 2021 B2
20010005787 Oz et al. Jun 2001 A1
20010014800 Frazier et al. Aug 2001 A1
20010023332 Hahnen Sep 2001 A1
20010031979 Ricci Oct 2001 A1
20010034528 Foerster et al. Oct 2001 A1
20010041821 Wilk Nov 2001 A1
20020013571 Goldfarb et al. Jan 2002 A1
20020013621 Stobie et al. Jan 2002 A1
20020026201 Foerster et al. Feb 2002 A1
20020029080 Mortier et al. Mar 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020042621 Liddicoat et al. Apr 2002 A1
20020065536 Hart et al. May 2002 A1
20020072757 Ahmed et al. Jun 2002 A1
20020077524 Schweich, Jr. et al. Jun 2002 A1
20020087048 Brock et al. Jul 2002 A1
20020087049 Brock et al. Jul 2002 A1
20020087148 Brock et al. Jul 2002 A1
20020087169 Brock et al. Jul 2002 A1
20020095167 Liddicoat et al. Jul 2002 A1
20020095175 Brock et al. Jul 2002 A1
20020095180 West, Jr. et al. Jul 2002 A1
20020138044 Streeter et al. Sep 2002 A1
20020156526 Hlavka et al. Oct 2002 A1
20020161378 Downing Oct 2002 A1
20020165486 Bertolero et al. Nov 2002 A1
20020165561 Ainsworth et al. Nov 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020183835 Taylor et al. Dec 2002 A1
20020193815 Foerster et al. Dec 2002 A1
20030009196 Peterson Jan 2003 A1
20030014060 Wilson, Jr. et al. Jan 2003 A1
20030018358 Saadat Jan 2003 A1
20030032979 Mortier et al. Feb 2003 A1
20030033006 Phillips et al. Feb 2003 A1
20030060813 Loeb et al. Mar 2003 A1
20030069593 Tremulis et al. Apr 2003 A1
20030074012 Nguyen et al. Apr 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078601 Shikhman et al. Apr 2003 A1
20030078603 Schaller et al. Apr 2003 A1
20030093118 Ho et al. May 2003 A1
20030105520 Alferness et al. Jun 2003 A1
20030125739 Bagga et al. Jul 2003 A1
20030125767 Collier et al. Jul 2003 A1
20030130731 Vidlund et al. Jul 2003 A1
20030144697 Mathis et al. Jul 2003 A1
20030158464 Bertolero Aug 2003 A1
20030158581 Levinson Aug 2003 A1
20030167062 Gambale et al. Sep 2003 A1
20030167071 Martin et al. Sep 2003 A1
20030181800 Bonutti Sep 2003 A1
20030199974 Lee et al. Oct 2003 A1
20030220685 Hlavka et al. Nov 2003 A1
20030225420 Wardle Dec 2003 A1
20030233105 Gayton Dec 2003 A1
20030233142 Morales et al. Dec 2003 A1
20030236535 Onuki et al. Dec 2003 A1
20040003819 St. Goar et al. Jan 2004 A1
20040019378 Hlavka et al. Jan 2004 A1
20040024414 Downing Feb 2004 A1
20040030382 St. Goar et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040092962 Thornton et al. May 2004 A1
20040093024 Lousararian et al. May 2004 A1
20040097788 Mourlas et al. May 2004 A1
20040122450 Oren et al. Jun 2004 A1
20040152947 Schroeder et al. Aug 2004 A1
20040162465 Carrillo Aug 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20040181238 Zarbatany et al. Sep 2004 A1
20040186378 Gesswein Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040204724 Kissel et al. Oct 2004 A1
20040210238 Nobles et al. Oct 2004 A1
20040236372 Anspach, III et al. Nov 2004 A1
20040236419 Milo Nov 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20050021054 Ainsworth et al. Jan 2005 A1
20050055052 Lombardo et al. Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050065550 Starksen et al. Mar 2005 A1
20050065589 Schneider et al. Mar 2005 A1
20050075723 Schroeder et al. Apr 2005 A1
20050080454 Drews et al. Apr 2005 A1
20050107810 Morales et al. May 2005 A1
20050107811 Starksen et al. May 2005 A1
20050107812 Starksen et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050119523 Starksen et al. Jun 2005 A1
20050119673 Gordon et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050184122 Hlavka et al. Aug 2005 A1
20050192599 Demarais Sep 2005 A1
20050192629 Saadat et al. Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050209690 Mathis et al. Sep 2005 A1
20050216078 Starksen et al. Sep 2005 A1
20050228452 Mourlas et al. Oct 2005 A1
20050251157 Saadat et al. Nov 2005 A1
20050251159 Ewers et al. Nov 2005 A1
20050251166 Vaughan et al. Nov 2005 A1
20050251177 Saadat et al. Nov 2005 A1
20050251205 Ewers et al. Nov 2005 A1
20050251207 Flores et al. Nov 2005 A1
20050251208 Elmer et al. Nov 2005 A1
20050251209 Saadat et al. Nov 2005 A1
20050251210 Westra et al. Nov 2005 A1
20050267495 Ginn et al. Dec 2005 A1
20050273138 To et al. Dec 2005 A1
20050277966 Ewers et al. Dec 2005 A1
20050277981 Maahs et al. Dec 2005 A1
20050277983 Saadat et al. Dec 2005 A1
20060015144 Burbank et al. Jan 2006 A1
20060025750 Starksen et al. Feb 2006 A1
20060025784 Starksen et al. Feb 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060058817 Starksen et al. Mar 2006 A1
20060069429 Spence et al. Mar 2006 A1
20060122633 To et al. Jun 2006 A1
20060129188 Starksen et al. Jun 2006 A1
20060161040 McCarthy et al. Jul 2006 A1
20060178682 Boehlke Aug 2006 A1
20060184203 Martin et al. Aug 2006 A1
20060190030 To et al. Aug 2006 A1
20060241656 Starksen et al. Oct 2006 A1
20060264975 Pipenhagen et al. Nov 2006 A1
20060271101 Saadat et al. Nov 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20060287661 Bolduc et al. Dec 2006 A1
20070005081 Findlay, III et al. Jan 2007 A1
20070005394 Bleyendaal et al. Jan 2007 A1
20070010857 Sugimoto et al. Jan 2007 A1
20070032820 Chin-Chen et al. Feb 2007 A1
20070038293 St.Goar et al. Feb 2007 A1
20070049942 Hindrichs et al. Mar 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070055206 To et al. Mar 2007 A1
20070112244 McCarthy et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070112424 Spence et al. May 2007 A1
20070112425 Schaller et al. May 2007 A1
20080045977 To et al. Feb 2008 A1
20080045982 To et al. Feb 2008 A1
20080045983 To et al. Feb 2008 A1
20080051810 To et al. Feb 2008 A1
20080051832 To et al. Feb 2008 A1
20080051837 To et al. Feb 2008 A1
20080058765 Jais et al. Mar 2008 A1
20080058868 To et al. Mar 2008 A1
20080172035 Starksen et al. Jul 2008 A1
20080177380 Starksen et al. Jul 2008 A1
20080228032 Starksen et al. Sep 2008 A1
20080234701 Morales et al. Sep 2008 A1
20080234702 Morales et al. Sep 2008 A1
20080234704 Starksen et al. Sep 2008 A1
20080234728 Starksen et al. Sep 2008 A1
20080234815 Starksen Sep 2008 A1
20080243150 Starksen et al. Oct 2008 A1
20080294177 To et al. Nov 2008 A1
20080312712 Penner Dec 2008 A1
20090054824 Melsheimer et al. Feb 2009 A1
20090182417 Tremulis et al. Jul 2009 A1
20090222083 Nguyen et al. Sep 2009 A1
20090234318 Loulmet et al. Sep 2009 A1
20090276038 Tremulis et al. Nov 2009 A1
20100049213 Serina et al. Feb 2010 A1
20100076548 Konno Mar 2010 A1
20100082098 Starksen et al. Apr 2010 A1
20100094248 Nguyen et al. Apr 2010 A1
20100094314 Hernlund et al. Apr 2010 A1
20100121349 Meier et al. May 2010 A1
20100198192 Serina et al. Aug 2010 A1
20110160528 Starksen Jun 2011 A1
20120101442 Legaspi et al. Apr 2012 A1
20120271331 To et al. Oct 2012 A1
20130304093 Serina et al. Nov 2013 A1
20140135799 Henderson May 2014 A1
20140148849 Serina et al. May 2014 A1
20140155783 Starksen et al. Jun 2014 A1
20140188140 Meier et al. Jul 2014 A1
20140194976 Starksen et al. Jul 2014 A1
20150164639 Starksen et al. Jun 2015 A1
20150182216 Morales et al. Jul 2015 A1
20170224489 Starksen et al. Aug 2017 A1
20190091023 Starksen et al. Mar 2019 A1
20200229820 Nguyen et al. Jul 2020 A1
Foreign Referenced Citations (53)
Number Date Country
103690202 Apr 2014 CN
0363661 Apr 1990 EP
0669101 Aug 1995 EP
1370546 Oct 1974 GB
H06510460 Nov 1994 JP
H11506628 Jun 1999 JP
2004000601 Jan 2004 JP
2007514455 Jun 2007 JP
4823295 Nov 2011 JP
WO-9308740 May 1993 WO
WO-9403227 Feb 1994 WO
WO-9515715 Jun 1995 WO
WO-9608208 Mar 1996 WO
WO-9639081 Dec 1996 WO
WO-9639942 Dec 1996 WO
WO-9727799 Aug 1997 WO
WO-9727807 Aug 1997 WO
WO-9730639 Aug 1997 WO
WO-9807375 Feb 1998 WO
WO-0060995 Oct 2000 WO
WO-0067640 Nov 2000 WO
WO-0126586 Apr 2001 WO
WO-0154618 Aug 2001 WO
WO-0203892 Jan 2002 WO
WO-0234167 May 2002 WO
WO-02051329 Jul 2002 WO
WO-02053011 Jul 2002 WO
WO-02085251 Oct 2002 WO
WO-02085252 Oct 2002 WO
WO-03088875 Oct 2003 WO
WO-03105667 Dec 2003 WO
WO-03105670 Dec 2003 WO
WO-2004037317 May 2004 WO
WO-2004082523 Sep 2004 WO
WO-2004082538 Sep 2004 WO
WO-2005025644 Mar 2005 WO
WO-2005062931 Jul 2005 WO
WO-2005102181 Nov 2005 WO
WO-2006037073 Apr 2006 WO
WO-2006097931 Sep 2006 WO
WO-2006116558 Nov 2006 WO
WO-2007001936 Jan 2007 WO
WO-2007005495 Jan 2007 WO
WO-2007021564 Feb 2007 WO
WO-2007021834 Feb 2007 WO
WO-2007035449 Mar 2007 WO
WO-2007056502 May 2007 WO
WO-2007100409 Sep 2007 WO
WO-2008028135 Mar 2008 WO
WO-2009100242 Aug 2009 WO
WO-2012031204 Mar 2012 WO
WO-2013112944 Aug 2013 WO
WO-2014183178 Nov 2014 WO
Non-Patent Literature Citations (156)
Entry
Extended European Search Report for European Application No. EP22155112.0 dated Sep. 19, 2022, 12 Pages.
De Simone, R. et al. (Apr. 1, 1994). “Adjustable Annuloplasty for Tricuspid Insufficiency with External Control,” Reader's Comments and Reply, Am. J. Cardiol. 73(9):721-722.
De Simone, R. et al. (Apr. 15, 1993). “Adjustable Tricuspid Valve Annuloplasty Assisted by Intraoperative Transesophageal Color Doppler Echocardiography,” Am. J. Cardiol. 71(11):926-931.
Downing, S.W. et al. (2002). “Feasibility of Off-Pump ASD Closure Using Real-Time 3-D Echocardiography,” The Heart Surgery Forum 5(2):96-99, Abstract 7025.
European Examination Communication dated Dec. 8, 2009, for EP Application No. 06 837 222.6 filed on Nov. 8, 2006, 3 pages.
Extended European Search Report dated Sep. 16, 2011, for EP Patent Application No. 11158898.4, filed on Sep. 1, 2004, 8 pages.
Extended European Search Report dated Sep. 9, 2011, for EP Patent Application No. 11158896.8, filed on Sep. 1, 2004, 7 pages.
Extended European Search Report dated Jan. 21, 2019, for EP Patent Application No. 16793570.9, filed on May 12, 2016, 2 pages.
Extended European Search Report dated Dec. 12, 2018, for EP Patent Application No. 18170269.7, filed on Sep. 1, 2004, 2 pages.
Final Office Action dated Apr. 10, 2009, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 8 pages.
Final Office Action dated Apr. 10, 2009, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 8 pages.
Final Office Action dated Apr. 14, 2008, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 11 pages.
Final Office Action dated Apr. 15, 2016, for U.S. Appl. No. 14/309,837, filed Jun. 19, 2014, 5 pages.
Final Office Action dated Apr. 2, 2008, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages.
Final Office Action dated Apr. 20, 2011, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 8 pages.
Final Office Action dated Apr. 29, 2009, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 9 pages.
Final Office Action dated Aug. 1, 2008, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages.
Final Office Action dated Aug. 13, 2007, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 9 pages.
Final Office Action dated Aug. 14, 2007, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 8 pages.
Final Office Action dated Aug. 30, 2007, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 9 pages.
Final Office Action dated Aug. 4, 2011, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 9 pages.
Final Office Action dated Aug. 6, 2007, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 12 pages.
Final Office Action dated Aug. 6, 2007, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 8 pages.
Final Office Action dated Dec. 6, 2011, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 7 pages.
Final Office Action dated Feb. 24, 2011, for U.S. Appl. No. 11/894,397, filed Aug. 20, 2007, 12 pages.
Final Office Action dated Feb. 24, 2011, for U.S. Appl. No. 11/894,468, filed Aug. 20, 2007, 12 pages.
Final Office Action dated Feb. 4, 2016, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 9 pages.
Final Office Action dated Feb. 5, 2015, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages.
Final Office Action dated Feb. 6, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 8 pages.
Final Office Action dated Jan. 22, 2009, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 9 pages.
Final Office Action dated Jul. 12, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages.
Final Office Action dated Jul. 21, 2009, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages.
Final Office Action dated Jul. 24, 2007, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 10 pages.
Final Office Action dated Jul. 26, 2010, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages.
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 12/132,161, filed Jun. 3, 2008, 13 pages.
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 12/187,331, filed Jun. 6, 2008, 7 pages.
Final Office Action dated Jun. 4, 2008, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages.
Final Office Action dated Jun. 8, 2010, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 17 pages.
Final Office Action dated Mar. 11, 2009, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 10 pages.
Final Office Action dated Mar. 17, 2011, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 13 pages.
Final Office Action dated Mar. 17, 2011, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 9 pages.
Final Office Action dated Mar. 19, 2012, for U.S. Appl. No. 12/574,563, filed Oct. 6, 2009, 6 pages.
Final Office Action dated Mar. 25, 2010, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 8 pages.
Final Office Action dated Mar. 3, 2010, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 7 pages.
Final Office Action dated May 28, 2008, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages.
Final Office Action dated Nov. 10, 2009, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages.
Final Office Action dated Nov. 10, 2011, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 20 pages.
Final Office Action dated Nov. 26, 2010, for U.S. Appl. No. 11/894,340, filed Aug. 20, 2007, 12 pages.
Final Office Action dated Nov. 29, 2010, for U.S. Appl. No. 11/894,463, filed Aug. 20, 2007, 12 pages.
Final Office Action dated Nov. 3, 2017, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages.
Final Office Action dated Oct. 13, 2009, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 11 pages.
Final Office Action dated Oct. 14, 2008, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages.
Final Office Action dated Oct. 30, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages.
Final Office Action dated Oct. 6, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages.
Final Office Action dated Sep. 14, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 8 pages.
Final Office Action dated Sep. 15, 2010, for U.S. Appl. No. 11/894,401, filed Aug. 20, 2007, 6 pages.
Final Office Action dated Sep. 2, 2009, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages.
Final Office Action dated Sep. 28, 2009, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages.
Final Office Action dated Sep. 30, 2008, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages.
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 7 pages.
Final Office Action dated Sep. 3, 2020, for U.S. Appl. No. 15/572,757, filed Nov. 8, 2017, 6 pages.
International Search Report dated Nov. 17, 2016 in PCT Application No. PCT/US2016/032220 filed May 12, 2016. 2 pages.
International Search Report dated Dec. 19, 2006, for PCT Application No. PCT/US2006/031190, filed Aug. 10, 2006, 4 pages.
International Search Report dated Apr. 2, 2007, for PCT Application No. PCT/US2006/043597, filed Nov. 8, 2006, 7 pages.
International Search Report dated Mar. 7, 2007, for PCT Patent Application No. PCT/US2004/028431, filed on Sep. 1, 2004, 1 page.
International Search Report dated Sep. 15, 2009, for PCT Patent Application No. PCT/US2009/033252, filed on Feb. 5, 2009, 1 page.
Nagy, Z.L. et al. (Dec. 2000). “Mitral Annuloplasty with a Suture Technique,” European Journal of Cardio-thoracic Surgery 18(6):739-740.
Non-Final Office Action (Supplementary) dated May 9, 2008, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages.
Non-Final Office Action dated Apr. 2, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages.
Non-Final Office Action dated Apr. 21, 2016, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 13 pages.
Non-Final Office Action dated Apr. 27, 2011, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 9 pages.
Non-Final Office Action dated Apr. 8, 2013, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 9 pages.
Non-Final Office Action dated Aug. 1, 2007, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 16 pages.
Non-Final Office Action dated Aug. 17, 2010, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 7 pages.
Non-Final Office Action dated Aug. 20, 2010, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 13 pages.
Non-Final Office Action dated Aug. 22, 2006, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages.
Non-Final Office Action dated Aug. 25, 2009, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages.
Non-Final Office Action dated Aug. 26, 2009, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 6 pages.
Non-Final Office Action dated Aug. 29, 2008, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages.
Non-Final Office Action dated Aug. 30, 2007, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages.
Non-Final Office Action dated Aug. 9, 2006, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 17 pages.
Non-Final Office Action dated Dec. 22, 2011, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 9 pages.
Non-Final Office Action dated Dec. 27, 2006, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages.
Non-Final Office Action dated Dec. 27, 2006, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages.
Non-Final Office Action dated Feb. 10, 2014, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 7 pages.
Non-Final Office Action dated Feb. 17, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 11 pages.
Non-Final Office Action dated Feb. 18, 2010, for U.S. Appl. No. 11/894,401, filed Aug. 20, 2007, 6 pages.
Non-Final Office Action dated Feb. 2, 2011, for U.S. Appl. No. 12/581,040, filed Oct. 16, 2009, 5 pages.
Non-Final Office Action dated Feb. 27, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 8 pages.
Non-Final Office Action dated Jan. 13, 2009, for U.S. Appl. No. 10/901,555, filed Jul. 27, 2004, 11 pages.
Non-Final Office Action dated Jan. 19, 2010, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages.
Non-Final Office Action dated Jan. 23, 2009, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages.
Non-Final Office Action dated Jan. 23, 2009, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages.
Non-Final Office Action dated Jan. 26, 2017, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages.
Non-Final Office Action dated Jan. 29, 2009, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 6 pages.
Non-Final Office Action dated Jan. 31, 2008, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages.
Non-Final Office Action dated Jan. 4, 2007, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages.
Non-Final Office Action dated Jan. 9, 2008, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages.
Non-Final Office Action dated Jul. 24, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages.
Non-Final Office Action dated Jul. 29, 2011, for U.S. Appl. No. 12/574,563, filed Oct. 6, 2009, 5 pages.
Non-Final Office Action dated Jun. 21, 2010, for U.S. Appl. No. 11/894,397, filed Aug. 20, 2007, 13 pages.
Non-Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 5 pages.
Non-Final Office Action dated Jun. 9, 2010, for U.S. Appl. No. 11/894,468, filed Aug. 20, 2007, 14 pages.
Non-Final Office Action dated Mar. 12, 2007, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 11 pages.
Non-Final Office Action dated Mar. 16, 2010, for U.S. Appl. No. 11/894,340, filed Aug. 20, 2007, 14 pages.
Non-Final Office Action dated Mar. 18, 2009, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 12 pages.
Non-Final Office Action dated Mar. 27, 2008, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages.
Non-Final Office Action dated Mar. 27, 2009, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages.
Non-Final Office Action dated Mar. 29, 2010, for U.S. Appl. No. 11/894,463, filed Aug. 20, 2007, 14 pages.
Non-Final Office Action dated Mar. 31, 2009, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages.
Non-Final Office Action dated Mar. 5, 2009, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages.
Non-Final Office Action dated Nov. 14, 2007, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 8 pages.
Non-Final Office Action dated Nov. 14, 2007, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 8 pages.
Non-Final Office Action dated Nov. 15, 2006, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 12 pages.
Non-Final Office Action dated Nov. 24, 2010, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 8 pages.
Non-Final Office Action dated Nov. 24, 2015, for U.S. Appl. No. 14/156,347, filed Jan. 15, 2014, 5 pages.
Non-Final Office Action dated Nov. 28, 2006, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 20 pages.
Non-Final Office Action dated Oct. 13, 2011, for U.S. Appl. No. 12/187,331, filed Aug. 6, 2008, 5 pages.
Non-Final Office Action dated Oct. 19, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 7 pages.
Non-Final Office Action dated Oct. 19, 2009, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 21 pages.
Non-Final Office Action dated Oct. 19, 2015, for U.S. Appl. No. 14/309,837, filed Jun. 19, 2014, 6 pages.
Non-Final Office Action dated Oct. 24, 2008, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 11 pages.
Non-Final Office Action dated Oct. 25, 2010, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 8 pages.
Non-Final Office Action dated Oct. 29, 2007, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 10 pages.
Non-Final Office Action dated Oct. 29, 2010, for U.S. Appl. No. 11/894,530, filed Aug. 20, 2007, 11 pages.
Non-Final Office Action dated Sep. 17, 2009, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 13 pages.
Non-Final Office Action dated Sep. 26, 2008, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 11 pages.
Non-Final Office Action dated Mar. 28, 2019, for U.S. Appl. No. 15/652,068, filed Jul. 17, 2017, 11 pages.
Non-Final Office Action dated Feb. 24, 2020, for U.S. Appl. No. 15/572,757, filed Nov. 8, 2017, 6 pages.
Notice of Allowance dated Apr. 28, 2010, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 7 pages.
Notice of Allowance dated Aug. 16, 2018, for U.S. Appl. No. 15/265,781, filed Sep. 14, 2016, 7 pages.
Notice of Allowance dated Aug. 4, 2009, for U.S. Appl. No. 10/901,555, filed Jul. 27, 2004, 7 pages.
Notice of Allowance dated Dec. 19, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 8 pages.
Notice of Allowance dated Dec. 6, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages.
Notice of Allowance dated Feb. 24, 2010, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 8 pages.
Notice of Allowance dated Jul. 26, 2011, for U.S. Appl. No. 11/894,530, filed Aug. 20, 2007, 10 pages.
Notice of Allowance dated Jun. 11, 2012, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages.
Notice of Allowance dated Jun. 15, 2016, for U.S. Appl. No. 14/156,347, filed Jan. 15, 2014, 7 pages.
Notice of Allowance dated Jun. 22, 2018, for U.S. Appl. No. 15/265,781, filed Sep. 14, 2016, 8 pages.
Notice of Allowance dated Mar. 17, 2014, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 8 pages.
Notice of Allowance dated Mar. 2, 2015, for U.S. Appl. No. 12/187,331, filed Aug. 6, 2008, 5 pages.
Notice of Allowance dated Nov. 17, 2010, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 11 pages.
Notice of Allowance dated Nov. 8, 2017, for U.S. Appl. No. 13/820,447, filed Oct. 18, 2013, 8 pages.
Notice of Allowance dated Oct. 29, 2015, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 8 pages.
Notice of Allowance dated Sep. 25, 2013, for U.S. Appl. No. 12/132,161, filed Jun. 3, 2008, 12 pages.
Notice of Allowance dated Sep. 16, 2019, for U.S. Appl. No. 15/652,068, filed Jul. 17, 2017, 8 pages.
Notice of Allowance dated Feb. 24, 2020, for U.S. Appl. No. 15/955,564, filed Apr. 17, 2018, 9 pages.
Notice of Allowance dated Dec. 23, 2020, for U.S. Appl. No. 15/572,757, filed Nov. 8, 2017, 8 pages.
Shumay, S.J. et al. (Dec. 1988). “A ‘Designer’ Annuloplasty Ring for Patients with Massive Mitral Annular Dilatation,” Ann. Thorac. Surg. 46(6):695-696.
Supplementary European Search Report dated Nov. 10, 2008, for EP Application No. 04 78 2847, filed on Sep. 1, 2004, 2 pages.
U.S. Appl. No. 11/875,774, filed Oct. 19, 2007, by Serina et al.
Written Opinion dated Nov. 17, 2016 in PCT Application No. PCT/US2016/032220 filed May 12, 2016. 4 pages.
Written Opinion of the International Searching Authority dated Apr. 2, 2007, for PCT Application No. PCT/US2006/043597, filed Nov. 8, 2006, 7 pages.
Written Opinion of the International Searching Authority dated Dec. 19, 2006, for PCT Application No. PCT/US2006/031190, filed Aug. 10, 2006, 6 pages.
Written Opinion of the International Searching Authority dated Mar. 7, 2007, for PCT Patent Application No. PCT/US2004/028431, filed on Sep. 1, 2004, 4 pages.
Written Opinion of the International Searching Authority dated Sep. 19, 2009, for PCT Patent Application No. PCT/US2009/033252, filed on Feb. 5, 2009, 7 pages.
Related Publications (1)
Number Date Country
20210290902 A1 Sep 2021 US
Provisional Applications (1)
Number Date Country
62160595 May 2015 US
Continuations (1)
Number Date Country
Parent 15572757 US
Child 17221321 US